We are live on ! Find out more
SCA

Strategic Capital Alternatives Portfolio holdings

AUM $6.3M
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$25.9M
Cap. Flow
-$37.4M
Cap. Flow %
-14.56%
Top 10 Hldgs %
28.24%
Holding
419
New
9
Increased
17
Reduced
71
Closed
319

Top Buys

Rank Stock Value
1
TBF icon
ProShares Short 20+ Year Treasury ETF
TBF
+$2.19M
2
ABBV icon
AbbVie
ABBV
+$1.81M
3
SPHY icon
State Street SPDR Portfolio High Yield Bond ETF
SPHY
+$1.8M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.58M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.49M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.39M
2
MDIV icon
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
+$2.94M
3
AAPL icon
Apple
AAPL
+$2.18M
4
OII icon
Oceaneering
OII
+$2.12M
5
AMZN icon
Amazon
AMZN
+$2.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.47%
2 Technology 12.11%
3 Healthcare 11.73%
4 Industrials 10.96%
5 Consumer Discretionary 6.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
126
Biogen
BIIB
$32.7B
– –
-109
Closed -$36K
BKNG icon
127
Booking.com
BKNG
$152B
– –
-1,225
Closed -$57K
BLK icon
128
Blackrock
BLK
$181B
– –
-88
Closed -$29K
BMO icon
129
Bank of Montreal
BMO
$120B
– –
-273
Closed -$20K
BMRN icon
130
BioMarin Pharmaceuticals
BMRN
$12.6B
– –
-214
Closed -$15K
BMY icon
131
Bristol-Myers Squibb
BMY
$137B
– –
-1,163
Closed -$60K
BRK.B icon
132
Berkshire Hathaway Class B
BRK.B
$1.08T
– –
-1,340
Closed -$185K
C icon
133
Citigroup
C
$223B
– –
-921
Closed -$48K
CAT icon
134
Caterpillar
CAT
$376B
– –
-2,470
Closed -$245K
CLH icon
135
Clean Harbors
CLH
$16.5B
– –
-11,024
Closed -$594K
CLX icon
136
Clorox
CLX
$12.5B
– –
-107
Closed -$10K
CMS icon
137
CMS Energy
CMS
$21.4B
– –
-1,000
Closed -$30K
COLB icon
138
Columbia Banking Systems
COLB
$8.68B
– –
-4,872
Closed -$121K
COP icon
139
ConocoPhillips
COP
$156B
– –
-2,755
Closed -$211K
COST icon
140
Costco
COST
$415B
– –
-1,222
Closed -$153K
CTSH icon
141
Cognizant
CTSH
$28.7B
– –
-934
Closed -$42K
CVS icon
142
CVS Health
CVS
$119B
– –
-197
Closed -$16K
CWB icon
143
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.68B
– –
-2,142
Closed -$106K
DBA icon
144
Invesco DB Agriculture Fund
DBA
$1.25B
– –
-30,149
Closed -$770K
DHI icon
145
D.R. Horton
DHI
$40.6B
– –
-4,690
Closed -$96K
DIS icon
146
Walt Disney
DIS
$184B
– –
-1,263
Closed -$112K
DON icon
147
WisdomTree US MidCap Dividend Fund
DON
$4.07B
– –
-525
Closed -$14K
DTE icon
148
DTE Energy
DTE
$28.3B
– –
-505
Closed -$33K
DUK icon
149
Duke Energy
DUK
$94.2B
– –
-711
Closed -$53K
DWX icon
150
State Street SPDR S&P International Dividend ETF
DWX
$531M
– –
-784
Closed -$36K
4 5
6
7 8

Similar funds

RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
TSU
TD Securities (USA) New York $11M AUM 2.35% 1-Year Est. Return
GFWEV
G.F.W. Energy VII Irving, Texas $1.49M AUM 89.53% 1-Year Est. Return
LCP
Lamond Capital Partners San Francisco, California $14.3M AUM 30.74% 1-Year Est. Return
HCM
Hirzel Capital Management Dallas, Texas $15.1M AUM 5.29% 1-Year Est. Return
PPF
PartnerRe Principal Finance Greenwich, Connecticut $15.5M AUM 13.01% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
USG2
Union Square GP 2004 New York $34.6M AUM

Strategic Capital Alternatives's Q4 2014 Portfolio in Review

As of Q4 2014, Strategic Capital Alternatives held 419 positions worth $257M, down 9.2% from $283M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Strategic Capital Alternatives withdrew a net $37.4M in Q4 2014, closing 319 positions and reducing 71 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $3.39M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Strategic Capital Alternatives opened a new position in Vertex Pharmaceuticals worth $1.67M.

  • Strategic Capital Alternatives's largest Q4 2014 buy was Vertex Pharmaceuticals: 14,026 shares worth $1.67M.
  • Strategic Capital Alternatives added most to ProShares Short 20+ Year Treasury ETF in Q4 2014, an estimated $2.19M increase.
  • Strategic Capital Alternatives's biggest Q4 2014 reduction was First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund, cutting an estimated $2.94M.
  • Strategic Capital Alternatives fully exited Alphabet (Google) Class C in Q4 2014, selling an estimated $3.39M.
  • Strategic Capital Alternatives's ten largest holdings make up 28% of its $257M portfolio in Q4 2014.
  • Strategic Capital Alternatives opened 9 new positions and closed 319 in Q4 2014.
  • Strategic Capital Alternatives's portfolio value fell 9.2% quarter-over-quarter to $257M.

Based on Strategic Capital Alternatives's 13F filing for Q4 2014, filed 18 Feb 2015.